Records containing: Recurrent Malignant Mesothelioma
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-03-20Ex-Vivo Expanded Allogeneic NK Cells for the Treatment of Solid Tumors of Pediatric Origin in Children and Young Adults
-
CLINICAL_TRIALS study record update · 2025-02-20A Prospective Study of Heated Intra-Peritoneal Chemotherapy (H.I.P.E.C.) With Doxorubicin and Cisplatin in Pediatric Patients With Pelvic and Abdominal Tumors. The TOAST IT Trial (Trial Of Adjuvant Surgical Treatment With Intraperitoneal Chemotherapy)
-
CLINICAL_TRIALS study record update · 2021-01-11A Phase 1 Trial of Oncolytic Measles Virotherapy in Mesothelioma
-
CLINICAL_TRIALS study record update · 2020-02-05A Phase I/Randomized Phase II Study of Cediranib (NSC#732208) Versus Placebo in Combination With Cisplatin and Pemetrexed in Chemonaive Patients With Malignant Pleural Mesothelioma
-
CLINICAL_TRIALS study record update · 2018-07-03HOPE Program: Quality of Life Enhancement and Survivorship Care
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2018-07-03A Pilot Study of Cryoablation for Patients With Oligometastatic Cancer Involving the Lung
-
CLINICAL_TRIALS study record update · 2016-10-24A Phase 2 Study of ARQ 197 in Patients With Previously-Treated Malignant Mesothelioma
-
CLINICAL_TRIALS study record update · 2015-10-21A Phase II Trial of Novel Oral Anti-Angiogenic Agent AZD2171 (NSC-732208) in Malignant Pleural Mesothelioma
-
CLINICAL_TRIALS study record update · 2014-12-29Phase II Study of PXD101 (NSC 726630) as Second-Line Therapy for Treatment of Patients With Malignant Pleural Mesothelioma
-
CLINICAL_TRIALS study record update · 2014-02-11A Double Blind, Placebo Controlled Randomized Phase II Trial Of Gemcitabine And Cisplatin With Or Without The VEGF Inhibitor Bevacizumab (NSC #704865) In Patients With Malignant Mesotheloma
-
CLINICAL_TRIALS study record update · 2013-12-13A Phase II Study of Sunitinib (SU11248; NSC 736511; IND 74019) in Patients With Advanced Malignant Pleural Mesothelioma
-
CLINICAL_TRIALS study record update · 2013-12-05Phase II Study of GW786034 in Patients With Malignant Pleural Mesothelioma
-
CLINICAL_TRIALS study record update · 2013-09-10Phase II Study of AZD2171 (NSC#732208) in Patients With Malignant Mesothelioma
-
CLINICAL_TRIALS study record update · 2013-08-02A Phase II Trial of AMG 102 in Combination With Pemetrexed and Cisplatin in Patients With Malignant Pleural Mesothelioma
-
CLINICAL_TRIALS study record update · 2013-06-05A Phase II Study of BAY 43-9006 (NSC #724772) in Patients With Malignant Mesothelioma
-
CLINICAL_TRIALS study record update · 2013-01-24A Phase II Study of Oral EGFR Tyrosine Kinase Inhibitor OSI-774 (NSC-718781) in Patients With Malignant Pleural Mesothelioma
-
CLINICAL_TRIALS study record update · 2013-01-17A Phase II Study Of ZD 1839 (NSC 715055, IND 61187) In Patients With Malignant Mesothelioma
-
CLINICAL_TRIALS study record update · 2013-01-16Phase I Study of OSI-774 (NSC 718781) for Solid Tumors in Patients With Hepatic or Renal Dysfunction
-
CLINICAL_TRIALS study record update · 2013-01-16The Detection of Tumor Hypoxia and Vascularity in Patients Undergoing Intraperitoneal Photodynamic Therapy